|   TG6-129 structure | Common Name | TG6-129 | ||
|---|---|---|---|---|
| CAS Number | 1164464-14-5 | Molecular Weight | 491.582 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C20H18FN5O3S3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Use of TG6-129TG6-129 is a selective antagonist of the EP2 receptor. TG6-129 reduces the expression of inflammatory factors induced by butaprost in P388D1 macrophages[1]. | 
| Name | TG6-129 | 
|---|---|
| Synonym | More Synonyms | 
| Description | TG6-129 is a selective antagonist of the EP2 receptor. TG6-129 reduces the expression of inflammatory factors induced by butaprost in P388D1 macrophages[1]. | 
|---|---|
| Related Catalog | |
| References | 
| Density | 1.5±0.1 g/cm3 | 
|---|---|
| Molecular Formula | C20H18FN5O3S3 | 
| Molecular Weight | 491.582 | 
| Exact Mass | 491.055573 | 
| LogP | 4.17 | 
| Index of Refraction | 1.697 | 
| 2-Propenamide, N-[[[4-[[(5-ethyl-1,3,4-thiadiazol-2-yl)amino]sulfonyl]phenyl]amino]thioxomethyl]-3-(4-fluorophenyl)-, (2E)- | 
| (2E)-N-({4-[(5-Ethyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl}carbamothioyl)-3-(4-fluorophenyl)acrylamide | 
| TG6-129 |